SEC FORM 4
$0.00
C4 Therapeutics, Inc. (CCCC)
Acquisition (code M) of 6,250 shares at $0 per share.
Reporting Person Adams Kendra · Officer Title Chief Financial Officer · Transaction Code M
Traded Sep 18, 2026 · Disclosed Sep 21, 2026
Source: SEC Form 4 · 0001470831-26-000895 · filed 2026-09-21 · View filing →